Clinically significant serrated polyp detection rates and risk for postcolonoscopy colorectal cancer: data from the New Hampshire Colonoscopy Registry.
Joseph C Anderson, William Hisey, Todd A Mackenzie...
https://pubmed.ncbi.nlm.nih.gov/35276209/Actively Recruiting
Led by Evergreen General Hospital, Taiwan · Updated on 2026-09-09
1090
Participants Needed
4
Research Sites
13 weeks
Total Duration
Researchers are comparing two methods to detect clinically significant serrated lesions CSSL during colonoscopy in adults aged 40 to 80 years. This study focuses on water exchange WE colonoscopy aided by artificial intelligence AI computer-aided detection CADe for colorectal cancer screening, surveillance, diagnosis, or after positive stool tests. The main question is whether adding linked-color imaging LCI to the AI-assisted WE colonoscopy improves lesion detection. Participants will be randomly assigned to one of two groups one using water exchange colonoscopy with AI-assisted detection alone, and the other using the same method combined with LCI. Both groups use specialized high-definition colonoscopy equipment with CADe systems during the withdrawal phase, and water infusion instead of air during insertion. The study uses consistent techniques to expand and clean the colon, with experienced endoscopists performing all procedures. During the study, participants undergo colonoscopy with sedation options ranging from none to full sedation. Researchers will collect data on lesion detection rates, including CSSL and other polyp types, based on pathology reports released one week after the procedure. The study is conducted across multiple centers over two years, with participants providing informed consent and undergoing randomization before the procedure. Safety and detection outcomes are closely monitored.
CONDITIONS
Computer-Aided Water Exchange Colonoscopy With and Without Linked-Color Imaging for Detection of Clinically Significant Serrated Lesions
C
Chi-Liang Cheng, MD
R
Rungsun Rerknimitr, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Evergreen General Hospital, Taiwan
Lead Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single procedure session
Participants undergo colonoscopy using water exchange with AI-assisted detection, with or without linked-color imaging, to evaluate lesion detection.
1 visit (in-person)
Duration - 1 week
Researchers review pathology reports and assess lesion detection rates about one week after the colonoscopy procedure.
1 follow-up visit or contact
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Joseph C Anderson, William Hisey, Todd A Mackenzie...
https://pubmed.ncbi.nlm.nih.gov/35276209/Joseph C Anderson, Douglas K Rex, Todd A Mackenzie...
https://pubmed.ncbi.nlm.nih.gov/37417792/Evergreen General Hospital, Taiwan
Lead Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborating Sponsor